Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 3946 AL 3960

Methodologies for assessing morphosyntactic ability in people with Alzheimer's disease

Varlokosta S, Fragkopoulou K, Arfani D, Manouilidou C.

Int J Lang Commun Disord. 2024 Jan-Feb;59(1):38-57. doi: 10.1111/1460-6984.12862. Epub 2023 Feb 25.

A Long-term Study of NeuroAid (MLC601, MLC901) in Patients with Alzheimer's Disease; An Extension 8-year Follow-up Study

Pakdaman H, Amini Harandi A, Gharagozli K, Siavoshi F, Shirzadeh Barough S, Sharifipour E, Esfandani A, Ilkhani S, Tabatabaei FS, Sobhanian SA.

Curr Aging Sci. 2023;16(3):234-239. doi: 10.2174/1874609816666230224111759.

Alzheimer's disease and COVID-19: Interactions, intrinsic linkages, and the role of immunoinflammatory responses in this process

Li W, Sun L, Yue L, Xiao S.

Front Immunol. 2023 Feb 9;14:1120495. doi: 10.3389/fimmu.2023.1120495. eCollection 2023.

Complementary and Alternative Medicine Approaches in Alzheimer Disease and Other Neurocognitive Disorders

Beversdorf DQ, Crosby HW, Shenker JI.

Mo Med. 2023 Jan-Feb;120(1):70-78.

Development of a home-based cognitive test for cognitive monitoring in subjective cognitive decline with high risk of Alzheimer's disease

Hong YJ, Lee SB, Kim SH, Lee MA, Park JW, Yang DW.

Medicine (Baltimore). 2023 Mar 3;102(9):e33096. doi: 10.1097/MD.0000000000033096.

Predictors of cognitive deterioration in subjective cognitive decline: evidence from longitudinal studies and implications for SCD-plus criteria

Li H, Tan CC, Tan L, Xu W.

J Neurol Neurosurg Psychiatry. 2023 Oct;94(10):844-854. doi: 10.1136/jnnp-2022-330246. Epub 2023 Mar 3.

Unlocking Modifiable Risk Factors for Alzheimer's Disease: Does the Oral Microbiome Hold Some of the Keys?

Loughman A, Adler CJ, Macpherson H.

J Alzheimers Dis. 2023;92(4):1111-1129. doi: 10.3233/JAD-220760.

Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation

Zhang M, Tang Z.

Biomed Pharmacother. 2023 May;161:114474. doi: 10.1016/j.biopha.2023.114474. Epub 2023 Mar 4.

Psychometric properties of the Alzheimer's Disease Cooperative Study - Activities of Daily Living for Mild Cognitive Impairment (ADCS-MCI-ADL) scale: a post hoc analysis of the ADCS ADC-008 trial

Potashman M, Pang M, Tahir M, Shahraz S, Dichter S, Perneczky R, Nolte S.

BMC Geriatr. 2023 Mar 6;23(1):124. doi: 10.1186/s12877-022-03527-0.

[Brain health services: individual dementia risk profiling at the Cologne Alzheimer Prevention Center]

Zeyen P, Sannemann L, Bohr L, Escher C, Müller T, Ramírez A, Rostamzadeh A, Jessen F.

Nervenarzt. 2023 May;94(5):392-399. doi: 10.1007/s00115-023-01451-1. Epub 2023 Mar 7.

Sleep-Related Changes Prior to Cognitive Dysfunction

Pérez-Carbonell L, Iranzo A.

Curr Neurol Neurosci Rep. 2023 Apr;23(4):177-183. doi: 10.1007/s11910-023-01258-2. Epub 2023 Mar 7.

Informant Characteristics Influence Reports of Participant Functioning and their Associations with Neuropsychological Performance in Non-Hispanic Black Adults

Graves LV, Hamill S, Larry M, Williams D.

Arch Clin Neuropsychol. 2023 Oct 20;38(7):1054-1067. doi: 10.1093/arclin/acad022.

Automatic Detection of Alzheimer's Disease using Deep Learning Models and Neuro-Imaging: Current Trends and Future Perspectives

Illakiya T, Karthik R.

Neuroinformatics. 2023 Apr;21(2):339-364. doi: 10.1007/s12021-023-09625-7. Epub 2023 Mar 8.

Receptor for Advanced Glycation End Products: Dementia and Cognitive Impairment

Singh A, Ansari VA, Mahmood T, Ahsan F, Wasim R, Shariq M, Parveen S, Maheshwari S.

Drug Res (Stuttg). 2023 Jun;73(5):247-250. doi: 10.1055/a-2015-8041. Epub 2023 Mar 8.

Design and development of the first randomized controlled trial of an intervention (IDEA) for sexual and gender minority older adults living with dementia and care partners

Fredriksen-Goldsen K, Teri L, Kim HJ, La Fazia D, McKenzie G, Petros R, Jung HH, Jones BR, Brown C, Emlet CA.

Contemp Clin Trials. 2023 May;128:107143. doi: 10.1016/j.cct.2023.107143. Epub 2023 Mar 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias